Amesite Inc.
Business
Amesite Inc. is a healthcare-focused technology company developing AI-powered solutions for the post-acute care market. The company operates two product lines under the NurseMagic™ brand: a B2C app for individual nurses and caregivers, and a B2B enterprise platform for healthcare organizations including home health, skilled nursing, and hospice facilities. NurseMagic™ addresses documentation, compliance, and workflow efficiency challenges through features designed for rapid deployment and regulatory compliance. The company also maintains the Amesite Engage platform for corporate learning, though it is not prioritizing growth in that segment. Distribution occurs through direct digital channels, self-service onboarding, and targeted enterprise sales.
Summary from 10-K filed 2025-09-29
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Net Revenue | 110,459 | 166,881 | 845,009 | 697,001 | 674,580 | |
| General and administrative expenses | 2 | 3 | 2 | 5 | 5 | |
| Technology and content development | 691,154 | 1 | 2 | 3 | — | |
| Sales and marketing expenses | 545,030 | 763,915 | 1 | 2 | 2 | |
| Total operating expenses | 4 | 5 | 5 | 10 | 9 | |
| Loss from Operations | −4 | −5 | −4 | −9 | — | |
| Interest income | 77,396 | 176,469 | 72,824 | — | 1,593 | |
| Impairment expense (Note 3) | −90,869 | — | — | — | — | |
| Total other income | −13,473 | 176,469 | 71,205 | — | — | |
| Net Loss | −4 | −4 | −4 | −9 | −12 | |
| Basic loss per share (in Dollars per share) | −1.03 | −1.73 | −1.68 | −4.67 | −0.59 | |
| Diluted loss per share (in Dollars per share) | −1.03 | −1.73 | −1.68 | −4.67 | −0.59 | |
| Weighted average shares outstanding (in Shares) | 4 | 3 | 2 | 2 | 20 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-11-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 2 | 2 | 5 | — | — | |
| Accounts receivable | 6,341 | 30,060 | 15,000 | — | — | |
| Prepaid expenses and other current assets | 94,100 | 403,489 | 106,679 | 560,084 | — | |
| Total current assets | 2 | 3 | 5 | 8 | — | |
| Restricted cash | 100,000 | 100,000 | — | — | — | |
| Property and equipment, net of accumulated depreciation of $142,907 and $117,559, respectively | 39,436 | 64,784 | 88,966 | 87,190 | — | |
| Capitalized software, net of accumulated amortization of $3,757,318 and $3,348,863, respectively | 523,804 | 644,828 | 778,446 | — | — | |
| Total noncurrent assets | 663,240 | 809,612 | 867,412 | 1 | — | |
| Total assets | 3 | 3 | 6 | 9 | — | |
| Accounts payable | 25,413 | 48,907 | 70,070 | 122,285 | — | |
| Accrued compensation | 243,198 | 655,275 | 64,500 | 174,056 | — | |
| Deferred revenue | 36,745 | — | 53,958 | 342,672 | — | |
| Other accrued liabilities | 53,240 | 94,283 | 76,799 | 109,095 | — | |
| Total current liabilities | 358,596 | 798,465 | 265,327 | 748,108 | — | |
| Common stock, $.0001 par value; 100,000,000 shares authorized; 4,572,713 and 2,542,440 shares issued and outstanding at June 30, 2025 and 2024, respectively. | 458 | 255 | 255 | 61,250 | 4,480 | |
| Preferred stock, $.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding at June 30, 2025 and 2024 | — | — | — | 0 | — | |
| Additional paid-in capital | 44 | 40 | 40 | 37 | — | |
| Accumulated earnings deficit | −41 | −38 | −33 | −29 | — | |
| Total stockholders equity | 3 | 3 | 6 | 8 | — | |
| Total liabilities and stockholders equity | 3 | 3 | 6 | 9 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 433,803 | 533,667 | 682,483 | 875,604 | 751,498 | |
| Stock-based compensation expense | 226,053 | 834,469 | 179,534 | 1 | 876,295 | |
| Warrants issued for underwriting fee | 95,984 | — | — | 148,948 | 1 | |
| Forfeiture of accrued director compensation | −200,000 | — | — | — | — | |
| Accounts receivable | 23,719 | −15,060 | −455 | 36,575 | 10,000 | |
| Prepaid expenses and other current assets | 309,389 | −296,810 | 453,405 | −260,695 | −72,115 | |
| Accounts payable | −23,494 | −21,163 | −52,212 | 77,918 | −46,800 | |
| Accrued compensation | 209,813 | 590,775 | −109,556 | — | — | |
| Deferred revenue | 36,745 | −53,958 | −288,714 | — | — | |
| Other accrued liabilities | −41,043 | 17,483 | −32,296 | — | — | |
| Net cash and cash equivalents used in operating activities | −2 | −3 | −3 | −7 | −5 | |
| Purchase of property and equipment | — | −1,166 | −27,124 | −16,575 | −73,427 | |
| Investment in capitalized software | −378,300 | −374,700 | — | — | — | |
| Net cash and cash equivalents used in investing activities | −378,300 | −375,866 | −396,033 | −711,622 | −842,326 | |
| Proceeds from the sale of common stock | 3 | — | 2 | 4 | 13 | |
| Net cash and cash equivalents provided by financing activity | 3 | — | 2 | 4 | 13 | |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 262,402 | −3 | −2 | −4 | 7 | |
| Settlement of restricted stock units through common stock issuance to directors | 399,975 | — | — | — | — | |
| Issuance of common stock for accrued director compensation | 21,890 | — | — | — | — | |
| Issuance of common stock for public offering consulting expenses | 655,000 | — | — | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Amesite Inc.'s CIK number?
Amesite Inc.'s SEC CIK number is 0001807166 (1807166). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Amesite Inc.'s SEC filings?
All of Amesite Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Amesite Inc. last report earnings?
Amesite Inc. (AMST) most recently filed an earnings 8-K with the SEC on May 16, 2025, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001213900-25-044897). This is Amesite Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Amesite Inc.'s most recent earnings 8-K?
Amesite Inc.'s latest earnings 8-K (Item 2.02) was filed May 16, 2025 under accession 0001213900-25-044897. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Amesite Inc.'s latest earnings 8-K →
Look up any company's CIK number →